MetaADEDB 2.0 @ LMMD
1-N'-[2-[[5-[(Dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine;hydron;chloride
(GGWBHVILAJZWKJ-UHFFFAOYSA-N)
Structure
SMILES
CNC(=C[N+](=O)[O-])NCCSCc1ccc(o1)CN(C)C.Cl
Molecular Formula:
C13H23ClN4O3S
Molecular Weight:
350.865
Log P:
3.5660
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
3
TPSA:
111.56
CAS Number(s):
66357-59-3; 71130-06-8
Synonym(s)
1.
1-N'-[2-[[5-[(Dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine;hydron;chloride
2.
Zantac 75
External Link(s)
PubChem Compound53395206
47909
CHEMBLCHEMBL2110372
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 629US FAERS
2DyspepsiaFAERS: 114US FAERS
3Accidental overdoseFAERS: 106US FAERS
4Accidental drug intake by childFAERS: 92US FAERS
5DizzinessFAERS: 73US FAERS
6VomitingFAERS: 72US FAERS
7NauseaFAERS: 69US FAERS
8HeadacheFAERS: 65US FAERS
9Drug screen positiveFAERS: 61US FAERS
10OverdoseFAERS: 52US FAERS
11PruritusFAERS: 49US FAERS
12Chest PainFAERS: 43US FAERS
13ConstipationFAERS: 43US FAERS
14Drug screen false positiveFAERS: 40US FAERS
15FlatulenceFAERS: 40US FAERS
16Incorrect dose administeredFAERS: 38US FAERS
17Feeling abnormalFAERS: 33US FAERS
18Urine amphetamine positiveFAERS: 33US FAERS
19Incorrect drug administration durationFAERS: 26US FAERS
20Amphetamines positiveFAERS: 25US FAERS
21UrticariaFAERS: 25US FAERS
22Accidental exposureFAERS: 24US FAERS
23No adverse eventFAERS: 23US FAERS
24DysgeusiaFAERS: 22US FAERS
25EructationFAERS: 22US FAERS
26Abdominal discomfortFAERS: 20US FAERS
27Abdominal PainFAERS: 19US FAERS
28Musculoskeletal PainFAERS: 19US FAERS
29SomnolenceFAERS: 19US FAERS
30Throat irritationFAERS: 19US FAERS
31FatigueFAERS: 18US FAERS
32MalaiseFAERS: 18US FAERS
33Wrong technique in drug usage processFAERS: 17US FAERS
34Medication ErrorFAERS: 16US FAERS
35PainFAERS: 16US FAERS
36Weight decreasedFAERS: 15US FAERS
37Back PainFAERS: 14US FAERS
38Unevaluable eventFAERS: 14US FAERS
39Chest discomfortFAERS: 13US FAERS
40Oropharyngeal painFAERS: 13US FAERS
41AstheniaFAERS: 12US FAERS
42ChromaturiaFAERS: 12US FAERS
43NervousnessFAERS: 12US FAERS
44TremorFAERS: 12US FAERS
45AnxietyFAERS: 10US FAERS
46Burning sensationFAERS: 10US FAERS
47PalpitationsFAERS: 10US FAERS
48AlopeciaFAERS: 9US FAERS
49Blood glucose increasedFAERS: 9US FAERS
50HypersensitivityFAERS: 9US FAERS
51ErythemaFAERS: 8US FAERS
52Lip swellingFAERS: 8US FAERS
53ArthralgiaFAERS: 7US FAERS
54Drug administration errorFAERS: 7US FAERS
55Feeling jitteryFAERS: 7US FAERS
56Inappropriate schedule of drug administrationFAERS: 7US FAERS
57Neck PainFAERS: 7US FAERS
58Product taste abnormalFAERS: 7US FAERS
59Drug ineffective for unapproved indicationFAERS: 6US FAERS
60LethargyFAERS: 6US FAERS
61Product use issueFAERS: 6US FAERS
62VertigoFAERS: 6US FAERS
63Wrong technique in product usage processFAERS: 6US FAERS
64Adverse eventFAERS: 5US FAERS
65Drug dispensing errorFAERS: 5US FAERS
66EpistaxisFAERS: 5US FAERS
67Erythema MultiformeFAERS: 5US FAERS
68Extra dose administeredFAERS: 5US FAERS
69GlossitisFAERS: 5US FAERS
70Intentional drug misuseFAERS: 5US FAERS
71Musculoskeletal chest painFAERS: 5US FAERS
72Product packaging issueFAERS: 5US FAERS
73Therapeutic response unexpectedFAERS: 5US FAERS
74WheezingFAERS: 5US FAERS
75AcneFAERS: 4US FAERS
76Blood cholesterol increasedFAERS: 4US FAERS
77ChillsFAERS: 4US FAERS
78Cold sweatFAERS: 4US FAERS
79DiscomfortFAERS: 4US FAERS
80Drug abuseFAERS: 4US FAERS
81DysphoniaFAERS: 4US FAERS
82Expired drug administeredFAERS: 4US FAERS
83Eye painFAERS: 4US FAERS
84MyalgiaFAERS: 4US FAERS
85Pharmaceutical product complaintFAERS: 4US FAERS
86Productive CoughFAERS: 4US FAERS
87SneezingFAERS: 4US FAERS
88SwellingFAERS: 4US FAERS
89Urinary IncontinenceFAERS: 4US FAERS
90AgitationFAERS: 3US FAERS
91Atrial FibrillationFAERS: 3US FAERS
92CryingFAERS: 3US FAERS
93DisorientationFAERS: 3US FAERS
94Drug ToleranceFAERS: 3US FAERS
95Expired product administeredFAERS: 3US FAERS
96Feeling ColdFAERS: 3US FAERS
97Gastrointestinal sounds abnormalFAERS: 3US FAERS
98LacerationFAERS: 3US FAERS
99NasopharyngitisFAERS: 3US FAERS
100No adverse reactionFAERS: 3US FAERS
101Opiates positiveFAERS: 3US FAERS
102Product quality issueFAERS: 3US FAERS
103RetchingFAERS: 3US FAERS
104Therapeutic reaction time decreasedFAERS: 3US FAERS
105Therapeutic response delayedFAERS: 3US FAERS
106UlcerFAERS: 3US FAERS
107Urinary tract infectionFAERS: 3US FAERS
108Anaphylactic shockFAERS: 2US FAERS
109Angina PectorisFAERS: 2US FAERS
110AnorexiaFAERS: 2US FAERS
111ArthritisFAERS: 2US FAERS
112Cerebrovascular accidentFAERS: 2US FAERS
113DehydrationFAERS: 2US FAERS
114Depressed moodFAERS: 2US FAERS
115Dry skinFAERS: 2US FAERS
116DysuriaFAERS: 2US FAERS
117Eye irritationFAERS: 2US FAERS
118False positive investigation resultFAERS: 2US FAERS
119False positive laboratory resultFAERS: 2US FAERS
120FlushingFAERS: 2US FAERS
121Gastric pH decreasedFAERS: 2US FAERS
122HyperchlorhydriaFAERS: 2US FAERS
123Increased upper airway secretionFAERS: 2US FAERS
124Infantile spitting upFAERS: 2US FAERS
125Laboratory test interferenceFAERS: 2US FAERS
126Limb injuryFAERS: 2US FAERS
127Muscle tightnessFAERS: 2US FAERS
128Musculoskeletal discomfortFAERS: 2US FAERS
129Nasal discomfortFAERS: 2US FAERS
130OsteopeniaFAERS: 2US FAERS
131Product storage errorFAERS: 2US FAERS
132Product use in unapproved indicationFAERS: 2US FAERS
133RegurgitationFAERS: 2US FAERS
134SyncopeFAERS: 2US FAERS
135TachycardiaFAERS: 2US FAERS
136Therapeutic product effect delayedFAERS: 2US FAERS
137ThrombosisFAERS: 2US FAERS
138TinnitusFAERS: 2US FAERS
139Tooth LossFAERS: 2US FAERS
140Visual ImpairmentFAERS: 2US FAERS
141Vulvovaginal pruritusFAERS: 2US FAERS
142Wrong drug administeredFAERS: 2US FAERS
143Abdominal tendernessFAERS: 1US FAERS
144Accidental exposure to productFAERS: 1US FAERS
145Accidental exposure to product by childFAERS: 1US FAERS
146AchlorhydriaFAERS: 1US FAERS
147AgeusiaFAERS: 1US FAERS
148Alcohol interactionFAERS: 1US FAERS
149Allergic reaction to excipientFAERS: 1US FAERS
150AmnesiaFAERS: 1US FAERS
151Anticoagulation drug level above therapeuticFAERS: 1US FAERS
152AphagiaFAERS: 1US FAERS
153AphoniaFAERS: 1US FAERS
154AsthmaFAERS: 1US FAERS
155Bipolar DisorderFAERS: 1US FAERS
156Bipolar I disorderFAERS: 1US FAERS
157Bladder painFAERS: 1US FAERS
158Blood alcohol increasedFAERS: 1US FAERS
159Blood glucose decreasedFAERS: 1US FAERS
160Blood potassium increasedFAERS: 1US FAERS
161Blood pressure fluctuationFAERS: 1US FAERS
162Blood sodium decreasedFAERS: 1US FAERS
163Blood testosterone decreasedFAERS: 1US FAERS
164Blood urine presentFAERS: 1US FAERS
165Bone painFAERS: 1US FAERS
166Bowel movement irregularityFAERS: 1US FAERS
167Cardiac ArrestFAERS: 1US FAERS
168Choking sensationFAERS: 1US FAERS
169ChokingFAERS: 1US FAERS
170ColitisFAERS: 1US FAERS
171CystitisFAERS: 1US FAERS
172DeliriumFAERS: 1US FAERS
173DementiaFAERS: 1US FAERS
174DermatitisFAERS: 1US FAERS
175Diabetes MellitusFAERS: 1US FAERS
176Drug DependenceFAERS: 1US FAERS
177Drug effect delayedFAERS: 1US FAERS
178Drug exposure before pregnancyFAERS: 1US FAERS
179Drug screen negativeFAERS: 1US FAERS
180Drug withdrawal syndromeFAERS: 1US FAERS
181DysarthriaFAERS: 1US FAERS
182DysgraphiaFAERS: 1US FAERS
183Ear congestionFAERS: 1US FAERS
184EczemaFAERS: 1US FAERS
185Electrolyte imbalanceFAERS: 1US FAERS
186EnuresisFAERS: 1US FAERS
187Epigastric discomfortFAERS: 1US FAERS
188Erectile dysfunctionFAERS: 1US FAERS
189FormicationFAERS: 1US FAERS
190Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
191GastritisFAERS: 1US FAERS
192GastroenteritisFAERS: 1US FAERS
193Gastrointestinal PainFAERS: 1US FAERS
194Gingival erythemaFAERS: 1US FAERS
195HungerFAERS: 1US FAERS
196HypersomniaFAERS: 1US FAERS
197HypomaniaFAERS: 1US FAERS
198Impaired work abilityFAERS: 1US FAERS
199Inappropriate schedule of product administrationFAERS: 1US FAERS
200Incorrect drug dosage form administeredFAERS: 1US FAERS
201InfluenzaFAERS: 1US FAERS
202Initial insomniaFAERS: 1US FAERS
203Intentional self-injuryFAERS: 1US FAERS
204Intraocular pressure test abnormalFAERS: 1US FAERS
205LabyrinthitisFAERS: 1US FAERS
206Limb discomfortFAERS: 1US FAERS
207Lower respiratory tract infectionFAERS: 1US FAERS
208LymphadenopathyFAERS: 1US FAERS
209Medication tamperingFAERS: 1US FAERS
210Memory impairmentFAERS: 1US FAERS
211MetrorrhagiaFAERS: 1US FAERS
212Musculoskeletal stiffnessFAERS: 1US FAERS
213MydriasisFAERS: 1US FAERS
214Myocardial InfarctionFAERS: 1US FAERS
215Nasal inflammationFAERS: 1US FAERS
216NephrolithiasisFAERS: 1US FAERS
217Night sweatsFAERS: 1US FAERS
218NocturiaFAERS: 1US FAERS
219Non-cardiac chest painFAERS: 1US FAERS
220Nontherapeutic agent urine positiveFAERS: 1US FAERS
221Oral painFAERS: 1US FAERS
222Oropharyngeal blisteringFAERS: 1US FAERS
223Oropharyngeal discomfortFAERS: 1US FAERS
224OsteoporosisFAERS: 1US FAERS
225Pancreatic carcinomaFAERS: 1US FAERS
226PancreatitisFAERS: 1US FAERS
227Pelvic PainFAERS: 1US FAERS
228Peptic UlcerFAERS: 1US FAERS
229PericarditisFAERS: 1US FAERS
230Perineal painFAERS: 1US FAERS
231PeriodontitisFAERS: 1US FAERS
232Peripheral swellingFAERS: 1US FAERS
233PetechiaeFAERS: 1US FAERS
234Pharyngolaryngeal PainFAERS: 1US FAERS
235Platelet count abnormalFAERS: 1US FAERS
236Product administration errorFAERS: 1US FAERS
237Product expiration date issueFAERS: 1US FAERS
238Product packaging difficult to openFAERS: 1US FAERS
239Product packaging quantity issueFAERS: 1US FAERS
240Product prescribing errorFAERS: 1US FAERS
241Product use complaintFAERS: 1US FAERS
242Pulmonary painFAERS: 1US FAERS
243Rash erythematousFAERS: 1US FAERS
244Rectal tenesmusFAERS: 1US FAERS
245Renal cystFAERS: 1US FAERS
246Renal painFAERS: 1US FAERS
247Respiratory arrestFAERS: 1US FAERS
248Respiratory tract congestionFAERS: 1US FAERS
249Rotator cuff syndromeFAERS: 1US FAERS
250Saliva alteredFAERS: 1US FAERS
251ScreamingFAERS: 1US FAERS
252Self-induced vomitingFAERS: 1US FAERS
253SinusitisFAERS: 1US FAERS
254Skin lacerationFAERS: 1US FAERS
255Skin reactionFAERS: 1US FAERS
256StomatitisFAERS: 1US FAERS
257StressFAERS: 1US FAERS
258Suicide attemptFAERS: 1US FAERS
259TensionFAERS: 1US FAERS
260Therapeutic product ineffective for unapproved indicationFAERS: 1US FAERS
261Therapy non-responderFAERS: 1US FAERS
262Therapy partial responderFAERS: 1US FAERS
263ThirstFAERS: 1US FAERS
264Tongue blisteringFAERS: 1US FAERS
265Tongue spasmFAERS: 1US FAERS
266Toxicologic test abnormalFAERS: 1US FAERS
267Transferrin abnormalFAERS: 1US FAERS
268Urinary sediment presentFAERS: 1US FAERS
269Urine alcohol test positiveFAERS: 1US FAERS
270Vulvovaginal burning sensationFAERS: 1US FAERS
271Vulvovaginal discomfortFAERS: 1US FAERS
272Vulvovaginal drynessFAERS: 1US FAERS
273YawningFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.